The constant changes in cancer cell bioenergetics are widely known as metabolic
reprogramming. Reprogramming is a process mediated by multiple factors, including …

Cancer stem cells (CSCs) are a subset of cancer cells with self-renewal ability and tumor
initiating properties. Unlike the other non-stem cancer cells, CSCs resist traditional therapy …

Increasing evidence indicate that cancer stem cells (CSCs) are the key driver of tumor
initiation and recurrence. The cellular and soluble components of the tumor …

Cancer stem cells (CSCs) are a subset of tumor cells that can initiate and sustain tumor
growth and cause recurrence and metastasis. CSCs are particularly resistant to …

Introduction Abnormal lipid metabolism, one of the hallmarks in cancer, has gradually
emerged as a novel target for cancer treatment. As organelles that store and release excess …

Primary liver cancer mainly includes the following four types: hepatocellular carcinoma
(HCC), cholangiocarcinoma (CCA), hepatoblastoma (HB), and combined hepatocellular …

Introduction Multiple myeloma (MM) is a malignant tumor caused by abnormal proliferation
of bone marrow (BM) plasma cells and is the second most common hematologic …

Pediatric neurological tumors are a heterogeneous group of cancers, many of which carry a
poor prognosis and lack a “standard of care” therapy. While they have similar anatomic …

The constant changes in cancer cell bioenergetics are widely known as metabolic
reprogramming. Reprogramming is a process mediated by multiple factors, including …

Glioblastoma multiforme is a malignant primary brain tumor with a poor prognosis and high
rates of chemo-radiotherapy failure, mainly due to a small cell fraction with stem-like …